Join to view full profile
1275 York AveNew York, NY 10065
Dr. Almassi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nima Almassi is a Urologic Oncologist at Cleveland Clinic. He obtained his medical degree from the Medical College of Wisconsin, completed urology residency training at Cleveland Clinic, and pursued fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center. He specializes in management of bladder, prostate, kidney, and penile cancer. His research interests includes bladder-sparing treatment in very high risk non-muscle invasive bladder cancer with variant histology, predictive biomarkers of treatment response to multimodal treatment of bladder cancer, the impact of body composition and sarcopenia on treatment outcomes in patients with urologic malignancy, and innovations in surgical treatment of urologic cancers.
Education & Training
Cleveland Clinic FoundationResidency, Urology, 2012 - 2018
Medical College of WisconsinClass of 2012
Certifications & Licensure
NY State Medical License 2017 - 2028
OH State Medical License 2020 - 2028
NJ State Medical License 2026 - 2027
American Board of Urology Urology
Publications & Presentations
PubMed
- Nonmuscle-invasive bladder cancer after solid organ transplantation: Clinical outcomes and recurrence patterns.Taeris Guzman, Sean McSweeney, Can Aydogdu, Gabriela Diaz, Mikayla Baer
Urologic Oncology. 2026-10-08 - 1 citationsHybrid grading systems improve progression risk stratification in non-invasive papillary urothelial carcinoma and support a histomorphological continuum of disease pro...Jane K Nguyen, Marcello P Toscano, Jianbo Li, Sean R Williamson, Christopher G Przybycin
Histopathology. 2026-08-10 - 1 citationsReducing complexity in International Bladder Cancer Group intermediate-risk non-muscle-invasive bladder cancer stratification: a three-factor approach.Jayant Siva, Can Aydogdu, Nicholas Heller, Rishi Jonnalagadda, Patrick J Hensley
BJU International. 2026-08-01
Press Mentions
Nerve-Sparing Cystectomy Preserves Sexual Function in Men with Bladder CancerJuly 3rd, 2025- BCG Response in Bladder Cancer Cases Linked to Tumor MicrobiomeMay 16th, 2023
- Gopa Iyer, MD, on Glandular-Phenotype Bladder CancerOctober 27th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
